Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Lauren Reoma MD

Lauren B. Reoma MD

Director, Clinical Trials Unit, Office of the Clinical Director, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland

Dr. Lauren B. Reoma is the Deputy Clinical Director and Director of the NINDS Clinical Trials Unit within intramural NINDS at the NIH. She is a board-certified neurologist who received her medical degree from and completed her neurology residency at the University of Florida College of Medicine. At NIH, she trained as a Clinical Fellow in the NINDS Neuroimmunology and Neurovirology Program where she completed additional training in Clinical Trials Methodology, Clinical Investigator Training, as well as rotated briefly through the Division of Neurology Products, CDER, FDA. She is the intramural fellowship director for the NINDS-FDA Division of Neurology Clinical Trials Methodology and Regulatory Science Fellowship in conjunction with CDER/FDA and extramural NINDS. Within NIH, she is a member of the NIH Institutional Review Board, the NIH Biosafety Committee, and oversees the NINDS central Data and Safety Monitoring Board. She is also the current Vice Chair of the AAN’s Experimental Neurotherapeutics Section and a member of the program committee of ASENT. Her research focuses on understanding the CNS viral reservoir as well as on developing practices for gold-standard early-phase clinical trials methodology and regulatory science in neurologic disease.

Recent Contributions to PracticeUpdate:

  1. Lentiviral Gene Therapy for Cerebral Adrenoleukodystrophy